MA

Madison Avenue Partners

North America, New York, United States, New York

Description

Madison Avenue Partners is an investment firm.

Investor Profile

Madison Avenue Partners has backed more than 3 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 2 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Post Ipo Equity rounds (top funding stages).
  • Majority of deals are located in United States.
  • Strong thematic focus on Biotechnology, Health Care, Therapeutics.

Stage Focus

  • Post Ipo Equity (100%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Health Care
  • Therapeutics
  • Genetics
  • Oncology
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Madison Avenue Partners frequently co-invest with?

EcoR1 Capital
North America, California, United States, San Francisco
Co-Investments: 3
Nantahala Capital Management
North America, Connecticut, United States, New Canaan
Co-Investments: 1
Farallon Capital Management
North America, California, United States, San Francisco
Co-Investments: 1
New Enterprise Associates
North America, California, United States, Menlo Park
Co-Investments: 2
Octagon Capital Advisors
North America, New York, United States, New York
Co-Investments: 1
Rock Springs Capital
North America, Maryland, United States, Baltimore
Co-Investments: 2
Armistice Capital
North America, New York, United States, New York
Co-Investments: 2
Invus
North America, New York, United States, New York
Co-Investments: 2
FK
North America, Pennsylvania, United States, Pittsburgh
Co-Investments: 1
Boxer Capital
North America, Florida, United States, Windermere
Co-Investments: 3

What are some of recent deals done by Madison Avenue Partners?

Gossamer Bio

San Diego, California, United States

Gossamer Bio is a biopharmaceutical company focused on the discovery and development of novel and differentiated therapeutic products.

BiotechnologyHealth CareTherapeutics
Post Ipo EquityJul 20, 2023
Amount Raised: $212,000,000
Gossamer Bio

San Diego, California, United States

Gossamer Bio is a biopharmaceutical company focused on the discovery and development of novel and differentiated therapeutic products.

BiotechnologyHealth CareTherapeutics
Post Ipo EquityJul 13, 2022
Amount Raised: $120,000,000
2seventy bio

Cambridge, Massachusetts, United States

2seventy bio is an immuno-oncology cell therapy company that discovers and develops cancer therapies.

BiotechnologyGeneticsHealth CareOncologyTherapeutics
Post Ipo EquityMar 16, 2022
Amount Raised: $170,000,000

Find More Investors Like Madison Avenue Partners

Discover similar investors in our database and build your perfect investor list.

Need help with your fundraising strategy?Read our fundraising guides

Madison Avenue Partners | Pipeseed